Risk adjusted net present value: What is the current valuation of Jazz Pharmaceuticals’s JZP-815?
The revenue for JZP-815 is expected to reach an annual total of $8 mn by 2037 in the US based off GlobalData’s Expiry Model. The drug’s revenue forecasts along with estimated costs are used to measure the value of an investment opportunity in that drug, …